A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy-Reference-Cited by-同舟云学术

A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy

Published:2009-10 Issue:43 Volume:27 Page:6088-6094
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Gandhi Rajesh T.,O’Neill David,Bosch Ronald J.,Chan Ellen S.,Bucy R. Pat,Shopis Janet,Baglyos Lynn,Adams Elizabeth,Fox Lawrence,Purdue Lynette,Marshak Ann,Flynn Theresa,Masih Reena,Schock Barbara,Mildvan Donna,Schlesinger Sarah J.,Marovich Mary A.,Bhardwaj Nina,Jacobson Jeffrey M.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference34 articles.

1. Dendritic cells and the promise of therapeutic vaccines for human immunodeficiency virus (HIV)-1;Walsh;Current HIV Reports,2003

2. Exploiting dendritic cells for active immunotherapy of cancer and chronic infections;O’Neill;Mol Biotechnol,2007

3. Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial;Russell;J Acquir Immune Defic Syndr,2007

4. Memory cytotoxic T lymphocyte responses in human immunodeficiency virus type 1 (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp 160 of HIV-1 and boosted with a recombinant gp160;Fleury;J Infect Dis,1996

5. Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group;Clements-Mann;J Infect Dis,1998

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of dendritic cells in cancer immunity and therapeutic strategies;International Immunopharmacology;2024-02

2. Smoothed simulated pseudo-maximum likelihood estimation for nonlinear mixed effects models with censored responses;Statistical Methods in Medical Research;2023-06-16

3. HIV post-treatment controllers have distinct immunological and virological features;Proceedings of the National Academy of Sciences;2023-03-06

4. Impact of oral administration of single strain Lactococcus lactis spp. cremoris on immune responses to keyhole limpet hemocyanin immunization and gut microbiota: A randomized placebo-controlled trial in healthy volunteers;Frontiers in Immunology;2022-12-07

5. Characterization of KLH-driven immune responses in clinical studies: A systematic review;Frontiers in Drug Discovery;2022-10-25